Indication
ATRT
4 clinical trials
4 products
Product
TazemetostatClinical trial
Heterogeneity in Rhabdoid Tumors : Proteomic and Single-Cell Analyses to Identify New Therapeutic TargetsStatus: Completed, Estimated PCD: 2023-02-17
Product
Mass spectrometryProduct
EflornithineClinical trial
Hétérogénéité Des Tumeurs Rhabdoides : Approches en " Cellules Uniques " Pour Identifier Des Cibles thérapeutiquesStatus: Recruiting, Estimated PCD: 2025-04-01
Product
Analyzes in Singles Cells